She received 100 mg PO hydralazine, 200 mg PO labetolol, zofran 4 mg IV, vancomycin 1 gram IV, levofloxacin 750 mg IV x 1 and was started on labetolol and nitroglycerin drips with control of her blood pressure to the 180s systolic.
She had a CXR which was concerning for volume overload.
Thrombotic events with negative hypercoagulability work-up - SVC thrombosis ([**2139**]); related to a catheter - Negative lupus anticoagulant ([**4-/2138**], [**8-/2138**], [**9-/2140**]) - Negative anticardiolipin antibodies IgG and IgM x4 ([**2137**]-[**2140**])  - Negative Beta-2 glycoprotein antibody ([**4-/2138**], [**8-/2140**]) 6.
HOCM: Last noted on echo [**8-17**] 7.
Thrombotic microangiopathy 12.
Physical Exam: On Admission per MICU team: Vitals: T: 96.5 BP: 162/120 HR: 79 RR: 13 O2: 100% on 4L General: Pleasant, comfortable, no distress HEENT: L eye enucleated.
Pertinent Results: [**2142-4-19**] 08:35AM   WBC-3.8* RBC-2.53* HGB-7.6* HCT-23.4* MCV-93 MCH-29.9 MCHC-32.3 RDW-19.9* [**2142-4-19**] 08:35AM   PLT COUNT-93* .
[**2142-4-19**] 08:35AM   GLUCOSE-88 UREA N-36* CREAT-6.0* SODIUM-135 POTASSIUM-5.7* CHLORIDE-101 TOTAL CO2-25 ANION GAP-15 [**2142-4-19**] 08:35AM   CALCIUM-9.4 PHOSPHATE-5.3* MAGNESIUM-2.0 .
CXR PA and LAT: IMPRESSION: 1.
Repeat imaging following diuresis could be considered.
INR trend: [**2142-4-19**] 09:30AM BLOOD PT-30.4* INR(PT)-3.1* [**2142-4-20**] 08:40AM BLOOD PT-28.3* PTT-45.3* INR(PT)-2.9* [**2142-4-21**] 04:07AM BLOOD PT-29.9* PTT-48.9* INR(PT)-3.1* [**2142-4-22**] 05:55AM BLOOD PT-33.3* PTT-54.1* INR(PT)-3.5*  Brief Hospital Course: 24 F with ESRD on hemodialysis, SLE, malignant hypertension, history of SVC syndrome, PRES who presented to the ICU for hypertensive emergency, dyspnea, and headache, now resolved.
Hypertensive Emergency: Patient's blood pressure normalized with transient nitroglycerin and labetalol drips.
She has received [**Year/Month/Day 2286**] and her blood pressures remained at her baseline off the drips.
- continue home blood pressure regimen - Nifedipine 150 mg Tablet SR daily - Hydralazine 100 mg Tablet Q8H - Labetalol 1000 mg Tablet TID - Aliskiren 150 mg Tablet PO BID - Clonidine 0.2 mg/24 hr Patch Weekly - Hydralazine 100 mg PO PRN for SBP > 200 - continue regular [**Year/Month/Day 2286**] schedule .
These episodes may be due to medication non-compliance and it may benefit Ms. [**Known lastname **] to be evaluated by an extended care facility to ensure proper blood pressure monitoring and health care in general.
Ultrafiltrate of 2 L on initial HD - continue outpatient regimen .
INR drifted up and was 3.5 on discharge.
Anemia: Hematocrit 24.5 initially.
Medications on Admission: Hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO Q4H Prednisone 1 mg Tablet Citalopram 20 mg Tablet Pantoprazole 40 mg Tablet, Warfarin 3 mg daily Gabapentin 300 mg TID Nifedipine 90 mg Tablet SR daily Nifedipine 60 mg Tablet SR daily Hydralazine 100 mg Tablet Q8H Labetalol 1000 mg Tablet TID Aliskiren 150 mg Tablet PO BID Clonidine 0.2 mg/24 hr Patch Weekly Docusate Sodium 100 mg Capsule PO BID Senna 8.6 mg Tablet Fentanyl 25 mcg/hr Patch 72 hr Lidocaine 5 %(700 mg/patch) daily Hydralazine 100 mg PO:PRN for SBP > 200  Discharge Medications: 1.
Hydralazine 50 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day) as needed: For systolic blood pressure > 200.
You were given antihypertensive drips and during [**Location (un) 2286**] 2 liters were taken off with good improvement in your shortness of breath.
Followup Instructions: Provider: [**First Name8 (NamePattern2) 2353**] [**Last Name (NamePattern1) 4758**], MD Phone:[**Telephone/Fax (1) 250**] Date/Time:[**2142-4-26**] 3:30 Provider: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **], MD Phone:[**Telephone/Fax (1) 2664**] Date/Time:[**2142-5-25**] 9:30    Completed by:[**2142-4-23**
